Evidence map›Paper›PMID 27429129›Full record

ArticleHealthcare (Basel, Switzerland)2013

Emerging Therapeutic Enhancement Enabling Health Technologies and Their Discourses: What Is Discussed within the Health Domain?

Gregor Wolbring, Lucy Diep, Sophya Yumakulov, Natalie Ball, Verlyn Leopatra, Dean Yergens

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gregor WolbringDepartment of Community Health Sciences, Specialization in Community Rehabilitation and Disability Studies, University of Calgary, Calgary, AB T2N4N1, Canada. gwolbrin@ucalgary.ca.
Lucy DiepDepartment of Community Health Sciences, Specialization in Community Rehabilitation and Disability Studies, University of Calgary, Calgary, AB T2N4N1, Canada. ldiep@ucalgary.ca.
Sophya YumakulovFaculty of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada. sophya.yumakulov@gmail.com.
Natalie BallFaculty of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada. neball@ucalgary.ca.
Verlyn LeopatraFaculty of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada. vgsleopa@ucalgary.ca.
Dean YergensFaculty of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada. dyergens@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

So far, the very meaning of health and therefore, treatment and rehabilitation is benchmarked to the normal or species-typical body. We expect certain abilities in members of a species; we expect humans to walk but not to fly, but a bird we expect to fly. However, increasingly therapeutic interventions have the potential to give recipients beyond species-typical body related abilities (therapeutic enhancements, TE). We believe that the perfect storm of TE, the shift in ability expectations toward beyond species-typical body abilities, and the increasing desire of health consumers to shape the health system will increasingly influence various aspects of health care practice, policy, and scholarship. We employed qualitative and quantitative methods to investigate among others how human enhancement, neuro/cognitive enhancement, brain machine interfaces, and social robot discourses cover (a) healthcare, healthcare policy, and healthcare ethics, (b) disability and (c) health consumers and how visible various assessment fields are within Neuro/Cogno/ Human enhancement and within the BMI and social robotics discourse. We found that health care, as such, is little discussed, as are health care policy and ethics; that the term consumers (but not health consumers) is used; that technology, impact and needs assessment is absent; and that the imagery of disabled people is primarily a medical one. We submit that now, at this early stage, is the time to gain a good understanding of what drives the push for the enhancement agenda and enhancement-enabling devices, and the dynamics around acceptance and diffusion of therapeutic enhancements.

Indexed as

assessmentbrain computer interfacebrain machine interfacecognitive enhancementdisabled peopleemerging therapeuticshealthcarehealth care ethicshealthcare ethicshealthcare policyhealth consumerhuman enhancementneuroenhancementpeople with disabilitiessocial roboticstherapeutic enhancement

Identifiers

PMID27429129
PMCPMC4934504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.